4-(4-acetyl-3-hydroxy-2-propylphenoxy)methylcinnamic acid | 87808-32-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-(4-acetyl-3-hydroxy-2-propylphenoxy)methylcinnamic acid
• 英文别名: (E)-3-[4-[(4-acetyl-3-hydroxy-2-propylphenoxy)methyl]phenyl]prop-2-enoic acid
• CAS: 87808-32-0
• 化学式: C₂₁H₂₂O₅
• 分子量: 354.403
• InChiKey: NBCHZAKVJHZVHW-FMIVXFBMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  26
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  83.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-(4-acetyl-3-hydroxy-2-propylphenoxy)methylcinnamic acid 在 三乙胺 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 生成 (E)-3-[4-(4-Acetyl-3-hydroxy-2-propyl-phenoxymethyl)-phenyl]-N-(1H-tetrazol-5-yl)-acrylamide
  参考文献：
  名称：

  Brown, Frederick J.; Bernstein, Peter R.; Cronk, Laura A., Journal of Medicinal Chemistry, 1989, vol. 32, # 4, p. 811 - 826

  摘要：

  DOI：
• 作为产物：
  描述：

  对甲基肉桂酸甲酯 在 lithium hydroxide 、 potassium carbonate 作用下， 以 四氢呋喃 、 甲醇 、 水 、 丙酮 为溶剂， 生成 4-(4-acetyl-3-hydroxy-2-propylphenoxy)methylcinnamic acid
  参考文献：
  名称：

  Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes

  摘要：

  Considerations of the possible similarities between leukotriene D4 and its prototypical antagonist, FPL 55712, led to the development of a new series of leukotriene antagonists incorporating a hydroxyacetophenone group (e.g., the toluic acids 16 and 18). Although considerable attention has focused on FPL 55712-derived analogues, only limited investigations into alternatives for the standard 4-acetyl-3-hydroxy-2-propylphenoxy moiety have been reported. Therefore, an extensive study of modifications to the hydroxyacetophenone portion of toluic acid 18 was undertaken. Although no viable alternative to the 3-hydroxy moiety was discovered, replacements for the 2-propyl group (34, 37) and the 4-acetyl functionality (56, 59) yielded potent antagonists. A number of compounds exhibited longer duration of action in vivo than FPL 55712.

  DOI：

  10.1021/jm00124a014

文献信息

• Pharmaceutically active phenylcarboxylic acid derivatives
  申请人：ICI Americas Inc.

  公开号：US04499299A1

  公开（公告）日：1985-02-12

  Compounds which antagonize the slow-reacting substance of anaphylaxis or components thereof, e.g., leukotrienes, in warm blooded animals as well as intermediates and methods for their preparation, pharmaceutical compositions and methods for their administration. The compounds are diphenyl carboxylic acids with particular linking groups between the individual phenyl rings and the carboxylic acid moiety. Particular utilities are to relieve asthma and inflammation in man.

  拮抗温血动物过敏性慢反应物质或其组分的化合物，例如白三烯，以及用于制备它们的中间体和方法，药物组合物及其给药方法。这些化合物是二苯甲酸，具有特定的连接基团，分别连接各个苯环和羧酸部分。特定的用途是用于缓解人类的哮喘和炎症。
• US4499299A
  申请人：——

  公开号：US4499299A

  公开（公告）日：1985-02-12
• Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes
  作者：Frederick J. Brown、Peter R. Bernstein、Laura A. Cronk、David L. Dosset、Kevin C. Hebbel、Thomas P. Maduskuie、Howard S. Shapiro、Edward P. Vacek、Ying K. Yee

  DOI：10.1021/jm00124a014

  日期：1989.4

  Considerations of the possible similarities between leukotriene D4 and its prototypical antagonist, FPL 55712, led to the development of a new series of leukotriene antagonists incorporating a hydroxyacetophenone group (e.g., the toluic acids 16 and 18). Although considerable attention has focused on FPL 55712-derived analogues, only limited investigations into alternatives for the standard 4-acetyl-3-hydroxy-2-propylphenoxy moiety have been reported. Therefore, an extensive study of modifications to the hydroxyacetophenone portion of toluic acid 18 was undertaken. Although no viable alternative to the 3-hydroxy moiety was discovered, replacements for the 2-propyl group (34, 37) and the 4-acetyl functionality (56, 59) yielded potent antagonists. A number of compounds exhibited longer duration of action in vivo than FPL 55712.
• Brown, Frederick J.; Bernstein, Peter R.; Cronk, Laura A., Journal of Medicinal Chemistry, 1989, vol. 32, # 4, p. 811 - 826
  作者：Brown, Frederick J.、Bernstein, Peter R.、Cronk, Laura A.、Dosset, David L.、Hebbel, Kevin C.、et al.

  DOI：——

  日期：——